Select Page

Drugs targeting ‘zombie cells’ show promise for treating chronic back pain

Drugs targeting ‘zombie cells’ show promise for treating chronic back pain

In a preclinical study, two drugs targeting ‘zombie cells’ have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide. Current treatments manage symptoms through painkillers or surgery, without addressing the root cause.

About The Author

Michael Jannicelli

Michael Jannicelli - "A PROVEN BUSINESS FIRESTARTER & BRANDING GENIUS" a true natural born Trendsetter. • Created over 100 products under 3 brands, sold in 30+ countries worldwide and influencing youth across the globe. • Featured in Forbes magazine +over 100 print publications, television talk shows, major motion pictures and national radio stations. • Co-founder and VP of Bliss beverage USA and President/co-founder of Socko International - fastest growing privately held beverage company in US (Forbes) with Hogan Energy & Raw Energy WWE. • Co-founder of Throwdown Industries (2003) - leading brand in multibillion dollar Impact/Action Sports Market (products designed for superior MN • Diagnosed with auto-immune diseases aged 13; using his experience to help others and promote a positive message while developing edgy products to benefit people with chronic illness.

Leave a reply

Your email address will not be published. Required fields are marked *